Cite
Drug-Induced Spruelike Enteropathy: What Clinicians Need to Know About Olmesartan.
MLA
Prichard, Wesley, et al. “Drug-Induced Spruelike Enteropathy: What Clinicians Need to Know About Olmesartan.” Consultant (00107069), vol. 56, no. 11, Nov. 2016, pp. 978–80. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edo&AN=119606869&authtype=sso&custid=ns315887.
APA
Prichard, W., Smither, F. C., Fick, L., West, E., Mehta, K., & Martin, A. (2016). Drug-Induced Spruelike Enteropathy: What Clinicians Need to Know About Olmesartan. Consultant (00107069), 56(11), 978–980.
Chicago
Prichard, Wesley, Fantley C. Smither, Laurel Fick, Evan West, Kapil Mehta, and Anthony Martin. 2016. “Drug-Induced Spruelike Enteropathy: What Clinicians Need to Know About Olmesartan.” Consultant (00107069) 56 (11): 978–80. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edo&AN=119606869&authtype=sso&custid=ns315887.